Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
NCT00445913
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
BIOLOGICAL:
Diabetes-suppressive dendritic cell vaccine
BIOLOGICAL:
control dendritic cells
Sponsor
University of Pittsburgh